DK0861897T3 - Rekombinante galdesaltaktiverede lipaser - Google Patents

Rekombinante galdesaltaktiverede lipaser

Info

Publication number
DK0861897T3
DK0861897T3 DK98200772T DK98200772T DK0861897T3 DK 0861897 T3 DK0861897 T3 DK 0861897T3 DK 98200772 T DK98200772 T DK 98200772T DK 98200772 T DK98200772 T DK 98200772T DK 0861897 T3 DK0861897 T3 DK 0861897T3
Authority
DK
Denmark
Prior art keywords
bal
cdna
pro
base
sequence
Prior art date
Application number
DK98200772T
Other languages
Danish (da)
English (en)
Inventor
Jordan J N Tang
Chi-Sun Wang
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of DK0861897T3 publication Critical patent/DK0861897T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1216—Other enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Dairy Products (AREA)
DK98200772T 1990-04-04 1991-04-04 Rekombinante galdesaltaktiverede lipaser DK0861897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50463590A 1990-04-04 1990-04-04
US07/537,426 US5200183A (en) 1987-11-19 1990-06-12 Recombinant bile salt activated lipases

Publications (1)

Publication Number Publication Date
DK0861897T3 true DK0861897T3 (da) 2003-09-29

Family

ID=27054892

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98200772T DK0861897T3 (da) 1990-04-04 1991-04-04 Rekombinante galdesaltaktiverede lipaser
DK91908492T DK0525076T3 (da) 1990-04-04 1991-04-04 Rekombinante galdesaltaktiverede lipaser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91908492T DK0525076T3 (da) 1990-04-04 1991-04-04 Rekombinante galdesaltaktiverede lipaser

Country Status (9)

Country Link
US (1) US5200183A (fr)
EP (2) EP0861897B1 (fr)
JP (3) JP3665329B2 (fr)
AT (2) ATE175356T1 (fr)
DE (2) DE69133279T2 (fr)
DK (2) DK0861897T3 (fr)
ES (2) ES2201401T3 (fr)
GR (1) GR3029711T3 (fr)
WO (1) WO1991015234A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173408A (en) * 1989-11-13 1992-12-22 Lange Louis George Iii Mammalian pancreatic cholesterol esterase
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
US5821226A (en) * 1994-12-01 1998-10-13 Oklahoma Medical Research Foundation BAL C-tail drug delivery molecules
US5696087A (en) * 1994-12-01 1997-12-09 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5681819A (en) * 1994-12-01 1997-10-28 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
SE9501939D0 (sv) * 1995-05-24 1995-05-24 Astra Ab DNA molecules for expression of polypeptides
US6342218B1 (en) 1997-02-14 2002-01-29 Oklahoma Medical Research Foundation Method for treatment of SLE
US7048917B1 (en) 1998-01-09 2006-05-23 Genzyme Corporation Fat-binding polymers
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US6299868B1 (en) 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6264937B1 (en) * 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US7049345B2 (en) * 2001-06-29 2006-05-23 Genzyme Corporation Fat-binding polymers
WO2012052060A1 (fr) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Procédé pour augmenter la vitesse de croissance de nourrissons humains
EP2629789A1 (fr) * 2010-10-21 2013-08-28 Swedish Orphan Biovitrum AB (Publ) Procédé pour augmenter l'absorption d'acides gras insaturés par des nourrissons humains
CA2835407A1 (fr) * 2011-05-18 2012-11-22 Swedish Orphan Biovitrum Ab (Publ) Procede de purification de proteine a faible ph
BR112014006798A2 (pt) * 2011-09-26 2017-06-13 Swedish Orphan Biovitrum Ab (Publ) formulações melhoradas de lípase estimulada por sal billiar humana recombinantes
KR20200018781A (ko) * 2017-06-19 2020-02-20 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 반감기 연장 폴리펩티드를 갖는 융합 단백질
WO2019201855A1 (fr) * 2018-04-16 2019-10-24 Swedish Orphan Biovitrum Ab (Publ) Protéine de fusion lysosomale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase

Also Published As

Publication number Publication date
GR3029711T3 (en) 1999-06-30
JP3665329B2 (ja) 2005-06-29
HK1011929A1 (en) 1999-07-23
DK0525076T3 (da) 1999-08-30
US5200183A (en) 1993-04-06
DE69130735T2 (de) 1999-06-17
EP0525076A4 (en) 1993-05-12
JPH05508763A (ja) 1993-12-09
DE69133279D1 (de) 2003-07-17
JP2001112468A (ja) 2001-04-24
EP0861897B1 (fr) 2003-06-11
JPH09132597A (ja) 1997-05-20
EP0861897A2 (fr) 1998-09-02
ATE242813T1 (de) 2003-06-15
EP0861897A3 (fr) 1999-05-12
ES2129026T3 (es) 1999-06-01
DE69130735D1 (de) 1999-02-18
WO1991015234A1 (fr) 1991-10-17
EP0525076B1 (fr) 1999-01-07
ES2201401T3 (es) 2004-03-16
DE69133279T2 (de) 2004-05-06
HK1021547A1 (en) 2000-06-16
EP0525076A1 (fr) 1993-02-03
ATE175356T1 (de) 1999-01-15

Similar Documents

Publication Publication Date Title
DK0525076T3 (da) Rekombinante galdesaltaktiverede lipaser
PT97992A (pt) Processo de preparacao de analogos polipeptidicos
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
EP0128041A3 (fr) Polypeptides ayant une activité de facteur de croissance du squelette
NO831317L (no) Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner.
DE68926888D1 (de) Verfahren zur Herstellung von sekretierten Rezeptoranalogen
IL84765A (en) 9-(1-carboxy-3-(guanidinophenyl)propylamino)octahydro-10-oxo-6h-pyridazo(1,2-a)-(1,2)diazepine-1-carboxylic acids and esters,their preparation and pharmaceutical compositions containing them and some intermediates therefor
CA2083177A1 (fr) Proteines surfactantes alveolaires
DE59101580D1 (de) Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.
BR9007115A (pt) Novo trombolitico
EP0249477A3 (fr) Polypeptides-analogues fonctionnels recombinants dépourvus d'acides aminés hydrophobes
EP0231132A3 (fr) Composition d'interleukine-2 recombinante et son procédé de préparation
DE68910771D1 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
IT8423659A0 (it) Procedimento per la risoluzione dell'acido (+)-6-metossi-alfa-metil-2-naftalenacetico nei corrispondenti antipodi ottici.
FR2756845B1 (fr) Sequence nucleotidique codant pour une flavine monooxygenase , proteine correspondante et composition destinee au diagnostic et a la therapie du glaucome
DE59109261D1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
DK440588D0 (da) Fremgangsmaade til fremstilling af polyurethan-(urinstof)-skumstoffer
NO881942L (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
DK340288A (da) Polypeptidanaloger og fremgangsmaade til fremstilling deraf
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
NO177536C (no) HIV-1-relaterte polypeptider, preparat som omfatter en blanding med minst to polypeptider, samt diagnostisk system og anvendelse av et polypeptid for måling av anti-HIV-1-antistoffer
RU1769857C (ru) Cпocoб диaгhoctиkи heokkлюзиbhoгo tpomбa hижheй пoлoй behы, pacпpoctpahяющeгocя c пoдbздoшho-бeдpehhoгo ceгmehta
FR2704236B1 (fr) Vecteur rétroviral pour la préparation de cellules recombinantes susceptibles d'être implantées in vivo dans un but thérapeutique.
IT8784934A0 (it) Procedimento per ottenere pietre artificiali da pavimenti e rivestimenti e pietre cosi'ottenute.
NO903995D0 (no) Fremgangsmaate for fremstilling av 1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylsyre og diestere derav.